Back to top

Buy Rating Reiterated on CRMD as Analyst Sees Undervalued Post-2027 Growth and Maintains $13 Price Target

In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Cormedix, with a price target of $13.00. Brandon Folkes ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CorMedix Inc (CRMD)